BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8689534)

  • 1. Modified Blalock-Taussig shunts: to heparinize or not to heparinize?
    Mullen JC; Lemermeyer G; Bentley MJ
    Can J Cardiol; 1996 Jul; 12(7):645-7. PubMed ID: 8689534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic versus modified Blalock-Taussig shunts in neonates and infants.
    Moulton AL; Brenner JI; Ringel R; Nordenberg A; Berman MA; Ali S; Burns J
    Circulation; 1985 Sep; 72(3 Pt 2):II35-44. PubMed ID: 4028366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic-pulmonary shunts in infants and children. Early and late results.
    Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency transcatheter balloon recanalization of acutely thrombosed modified Blalock-Taussig shunts.
    Sivakumar K; Anil SR; Ravichandra M; Natarajan KU; Kamath P; Kumar RK
    Indian Heart J; 2001; 53(6):743-8. PubMed ID: 11838928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blalock-Taussig shunts and modified Blalock-Taussig shunts.
    Sanchez HE; Vosloo S
    S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
    de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modified Blalock-Taussig shunt: a 6-year experience from a developing country.
    Maghur HA; Ben-Musa AA; Salim ME; Abuzakhar SS
    Pediatr Cardiol; 2002; 23(1):49-52. PubMed ID: 11922508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.
    Ahmad U; Fatimi SH; Naqvi I; Atiq M; Moizuddin SS; Sheikh KB; Shahbuddin S; Naseem TM; Javed MA
    Heart Lung Circ; 2008 Feb; 17(1):54-8. PubMed ID: 17683985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term patency after the Blalock-Taussig operation--comparison between classic and modified shunts].
    Ohuchi H; Okabe H; Nagata N; Koseni K; Kaneko Y; Itoh K
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1108-13. PubMed ID: 8828367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance imaging: evaluation of the Blalock-Taussig shunts and anatomy of the pulmonary artery].
    Ichida F; Hashimoto I; Miyazaki A; Tsubata S; Okada T; Murakami A; Nakajima A; Futatsuya R
    J Cardiol; 1992; 22(4):669-78. PubMed ID: 1343633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Blalock-Taussig shunt in newborn infants.
    Ilbawi MN; Grieco J; DeLeon SY; Idriss FS; Muster AJ; Berry TE; Klich J
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):770-5. PubMed ID: 6492843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Blalock-Taussig shunt in the newborn infant.
    Smith VC; Caggiano AV; Knauf DG; Alexander JA
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):602-5. PubMed ID: 1717795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth of the pulmonary arteries and morphological assessment after Blalock-Taussig shunts].
    Honda J
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):569-77. PubMed ID: 8515154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt.
    Amato JJ; Marbey ML; Bush C; Galdieri RJ; Cotroneo JV; Bushong J
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):62-9. PubMed ID: 2447447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease.
    Sahoo TK; Chauhan S; Sahu M; Bisoi A; Kiran U
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):179-83. PubMed ID: 17418728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Blalock-Taussig shunt. Low risk, effective palliation, and pulmonary artery growth.
    Guyton RA; Owens JE; Waumett JD; Dooley KJ; Hatcher CR; Williams WH
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):917-22. PubMed ID: 6190047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of the construction of a Blalock-Taussig shunt in adolescents and adults.
    Peries A; Al-Hay AA; Shinebourne EA
    Cardiol Young; 2005 Aug; 15(4):368-72. PubMed ID: 16014183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polytetrafluoroethylene shunts in congenital heart disease.
    Nanton MA; Roy DL; Murphy DM; Finley JP; Lau H; Gillis DA; Murphy DA
    Can J Surg; 1982 Mar; 25(2):134-8. PubMed ID: 7066772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Blalock-Taussig shunt: technical aspects and postoperative management.
    Swain SK; Dharmapuram AK; Reddy P; Ramdoss N; Raghavan SS; Kona SM
    Asian Cardiovasc Thorac Ann; 2008 Jan; 16(1):7-10. PubMed ID: 18245697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Blalock-Taussig shunt using allograft saphenous vein: six years' experience.
    Bogáts G; Kertész E; Katona M; Tószegi A; Kovács GS
    Ann Thorac Surg; 1996 Jan; 61(1):58-62. PubMed ID: 8561638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.